Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592)

被引：2

作者：

Freedman, Arnold S. ^{[1
]}

Kuruvilla, John ^{[2
]}

Assouline, Sarit E. ^{[3
,4
]}

Engert, Andreas ^{[5
]}

Heo, DaeSeog ^{[6
]}

Solal-Celigny, Philippe ^{[7
]}

Corradini, Paolo ^{[8
]}

Verhoef, Gregor ^{[9
]}

Fanale, Michelle A. ^{[10
]}

Bendiske, Jennifer ^{[11
]}

Ewald, Brett ^{[11
]}

Dey, Jyotirmoy ^{[11
]}

Baeck, Johan ^{[11
]}

Younes, Anas ^{[10
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Toronto, Princess Space Margaret Hosp, Toronto, PQ, Canada

[3] McGill Univ, Jewish Gen Hosp, Div Hematol, Montreal, PQ H3T 1E2, Canada

[4] McGill Univ, Jewish Gen Hosp, Dept Oncol, Montreal, PQ H3T 1E2, Canada

[5] Univ Hosp Cologne, German Hodgkin Study Grp GHSG, Dept Internal Med 1, Cologne, Germany

[6] Seoul Natl Univ, Seoul, South Korea

[7] Clin Victor Hugo, Ctr Jean Bernard, Le Mans, France

[8] Univ Milan, Fdn IRCCS, Ist Nazl Tumori, Milan, Italy

[9] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium

[10] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[11] Novartis Pharmaceut Inc, Florham Pk, NJ USA

来源：

关键词：

D O I：

10.1182/blood.V116.21.284.284

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：129 / 129

页数：1